Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immutep ADS Representing 10 Ord Shs
IMMP
Healthcare
Biotechnology
Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to...
drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IMMP)
New Post
View:
Posts & Comments
Threaded Posts
(79)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Jul 15, 2024 7:41pm
It was a buy for me today,play it again Sam.
I played this one about 5 years ago,and it was time for me to do it again,for it should be a nice triple your money for me with this one,using my charts,so glta with it.
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jul 15, 2024 7:16pm
Immutep Up as Combo Therapy Meets Carcinoma Study Goals | Be
Breaking News: $IMMP Immutep Up as Combo Therapy Meets Carcinoma Study Goals | BenzingaImmutep Limited@(NASDAQ: IMMP) jumped 14.9% after it announced positive results from cohort B of the late-stage
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jul 12, 2024 11:02am
QS, SWN, IMMP, KEY, NCLH showing five-day upward surge
Breaking News: $IMMP QS, SWN, IMMP, KEY, NCLH showing five-day upward surge2024-07-12 10:45:04 ET QuantumScape Corp (QS) QS is trading UP for the last 5 days, and it at trading at $7.84 with volume of
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 27, 2024 5:15pm
IMMP Price Target Alert: $6.00. Issued by Robert W. Baird
Just In: $IMMP IMMP Price Target Alert: $6.00. Issued by Robert W. Baird2024-06-27 08:00:12 ET Joel Beatty from Robert W. Baird issued a price target of $6.00 for IMMP on 2024-06-27 06:42:00. The
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 24, 2024 11:15am
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring
Just In: $IMMP Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? | BenzingaWednesday,@Immutep Limited@(NASDAQ:IMMP)@released@preliminary topline results from Cohort B of the
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >